Found: 58
Select item for more details and to access through your institution.
The challenges of control groups, placebos and blinding in clinical trials of dietary interventions.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 4, p. 404, doi. 10.1111/apt.17609
- By:
- Publication type:
- Article
Review article: guide to tofacitinib dosing in patients with ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 7, p. 1131, doi. 10.1111/apt.17185
- By:
- Publication type:
- Article
A retrospective cohort study: pre‐operative oral enteral nutritional optimisation for Crohnʼs disease in a UK tertiary IBD centre.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 4, p. 646, doi. 10.1111/apt.17055
- By:
- Publication type:
- Article
Review article: randomised controlled trials in inflammatory bowel disease—common challenges and potential solutions.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 6, p. 658, doi. 10.1111/apt.16781
- By:
- Publication type:
- Article
An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 678, doi. 10.1111/apt.16497
- By:
- Publication type:
- Article
Editorial: is tofacitinib another rescue option for acute severe ulcerative colitis?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 3, p. 341, doi. 10.1111/apt.16482
- By:
- Publication type:
- Article
Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO‐LEVEL study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 292, doi. 10.1111/apt.15808
- By:
- Publication type:
- Article
HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.
- Published in:
- Nature Genetics, 2014, v. 46, n. 10, p. 1131, doi. 10.1038/ng.3093
- By:
- Publication type:
- Article
Are We Using and Monitoring Thiopurines and Biologics Optimally?
- Published in:
- Digestive Diseases, 2014, v. 32, n. 4, p. 410, doi. 10.1159/000358147
- By:
- Publication type:
- Article
Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases.
- Published in:
- Drugs, 2020, v. 80, n. 2, p. 99, doi. 10.1007/s40265-020-01256-5
- By:
- Publication type:
- Article
Recurrent Campylobacter jejuni Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)—A Case Report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Early recapture of response with tofacitinib 10 mg twice daily in patients with ulcerative colitis in OCTAVE Open following dose reduction or treatment interruption in OCTAVE Sustain.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 2, p. 264, doi. 10.1111/jgh.16386
- By:
- Publication type:
- Article
Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis.
- Published in:
- Clinical & Experimental Gastroenterology, 2017, v. 10, p. 57, doi. 10.2147/CEG.S110547
- By:
- Publication type:
- Article
The challenges of control groups, placebos and blinding in clinical trials of dietary interventions.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
- Published in:
- Digestive Diseases & Sciences, 2022, v. 67, n. 3, p. 1018, doi. 10.1007/s10620-021-06932-4
- By:
- Publication type:
- Article
Vedolizumab Dose Escalation: In for a Penny, in for a Pound?
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Incorporating patient experience into drug development for ulcerative colitis: development of the Urgency Numeric Rating Scale, a patient-reported outcome measure to assess bowel urgency in adults.
- Published in:
- Journal of Patient-Reported Outcomes, 2022, v. 6, n. 1, p. 1, doi. 10.1186/s41687-022-00439-w
- By:
- Publication type:
- Article
Long‐term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome.
- Published in:
- Neurogastroenterology & Motility, 2022, v. 34, n. 4, p. 1, doi. 10.1111/nmo.14241
- By:
- Publication type:
- Article
Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 4, p. 277, doi. 10.1007/s40261-023-01252-z
- By:
- Publication type:
- Article
Effectiveness and safety of vedolizumab in inflammatory bowel disease patients aged 60 and over: an observational multicenter UK experience.
- Published in:
- Annals of Gastroenterology, 2020, v. 33, n. 2, p. 170, doi. 10.20524/aog.2020.0447
- By:
- Publication type:
- Article
Autologous stem cell transplantation with low-dose cyclophosphamide to improve mucosal healing in adults with refractory Crohn's disease: the ASTIClite RCT.
- Published in:
- Efficacy & Mechanism Evaluation (EME), 2024, v. 11, n. 3, p. vii, doi. 10.3310/CGLT7102
- By:
- Publication type:
- Article
Regulatory T cells and immunoglobulin E: A new therapeutic link for autoimmunity?
- Published in:
- Allergy, 2022, v. 77, n. 11, p. 3293, doi. 10.1111/all.15449
- By:
- Publication type:
- Article
Editorial: establishing a joint approach to a common problem for gastroenterologists.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 2, p. 306, doi. 10.1111/apt.15589
- By:
- Publication type:
- Article
Letter: immune checkpoint inhibitor‐induced colitis—shouldn't we be checking more often?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 472, doi. 10.1111/apt.15393
- By:
- Publication type:
- Article
Golimumab in the treatment of ulcerative colitis.
- Published in:
- Therapeutic Advances in Gastroenterology, 2019, v. 12, p. N.PAG, doi. 10.1177/1756284818821266
- By:
- Publication type:
- Article
Golimumab in the treatment of ulcerative colitis.
- Published in:
- Therapeutic Advances in Gastroenterology, 2019, v. 12, p. N.PAG, doi. 10.1177/1756284818821266
- By:
- Publication type:
- Article
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 6, p. 790, doi. 10.1093/ecco-jcc/jjad203
- By:
- Publication type:
- Article
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 4, p. 560, doi. 10.1093/ecco-jcc/jjad182
- By:
- Publication type:
- Article
Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 Trial.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 3, p. 416, doi. 10.1093/ecco-jcc/jjad168
- By:
- Publication type:
- Article
Thiopurines for Ulcerative Colitis: Old Favourite or Old Hat?
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 7, p. 1029, doi. 10.1093/ecco-jcc/jjad062
- By:
- Publication type:
- Article
Ustekinumab-Induced Inflammatory Demyelinating Polyneuropathy in a Patient with Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 1, p. 144, doi. 10.1093/ecco-jcc/jjac116
- By:
- Publication type:
- Article
Thromboprophylaxis Use in Paediatric Inflammatory Bowel Disease: An International RAND Appropriateness Panel.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 10, p. 1609, doi. 10.1093/ecco-jcc/jjac073
- By:
- Publication type:
- Article
Anogenital Crohn's Disease and Granulomatosis: A Systematic Review of Epidemiology, Clinical Manifestations, and Treatment.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 5, p. 822, doi. 10.1093/ecco-jcc/jjab211
- By:
- Publication type:
- Article
Nutrient, Fibre, and FODMAP Intakes and Food-related Quality of Life in Patients with Inflammatory Bowel Disease, and Their Relationship with Gastrointestinal Symptoms of Differing Aetiologies.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 12, p. 2041, doi. 10.1093/ecco-jcc/jjab116
- By:
- Publication type:
- Article
Crohn's Disease-associated IL2RA Enhancer Variant Determines the Balance of T Cell Immunity by Regulating Responsiveness to IL-2 Signalling.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 12, p. 2054, doi. 10.1093/ecco-jcc/jjab103
- By:
- Publication type:
- Article
Response to 'Clinical Efficacy of Tofacitinib in Moderate to Severe Ulcerative Colitis'.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 10, p. 1775, doi. 10.1093/ecco-jcc/jjab080
- By:
- Publication type:
- Article
Clinical Trials [and Tribulations]: The Immediate Effects of COVID-19 on IBD Clinical Research Activity in the UK.
- Published in:
- Journal of Crohn's & Colitis, 2020, v. 14, n. 12, p. 1769, doi. 10.1093/ecco-jcc/jjaa137
- By:
- Publication type:
- Article
Clinical Features and Genetic Risk of Demyelination Following Anti-TNF Treatment.
- Published in:
- Journal of Crohn's & Colitis, 2020, v. 14, n. 12, p. 1653, doi. 10.1093/ecco-jcc/jjaa104
- By:
- Publication type:
- Article
Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience.
- Published in:
- Journal of Crohn's & Colitis, 2020, v. 14, n. 10, p. 1385, doi. 10.1093/ecco-jcc/jjaa075
- By:
- Publication type:
- Article
Authors' Reply to: Type C Mucosa in Pouch Surveillance: Make-do and Mend Rather Than Start From Scratch?
- Published in:
- Journal of Crohn's & Colitis, 2020, v. 14, n. 8, p. 1181, doi. 10.1093/ecco-jcc/jjaa045
- By:
- Publication type:
- Article
Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: A Randomised, Double-blind, Placebo-controlled, Cross-over, Re-challenge Trial.
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 12, p. 1420, doi. 10.1093/ecco-jcc/jjx073
- By:
- Publication type:
- Article
ECCO IBD Curriculum.
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 9, p. 1039, doi. 10.1093/ecco-jcc/jjx004
- By:
- Publication type:
- Article
Role of Therapeutic Drug Monitoring for Biologics in IBD.
- Published in:
- Inflammatory Bowel Disease Monitor, 2014, v. 14, n. 2, p. 44
- By:
- Publication type:
- Article
Systematic Literature Review and Meta-analysis: Real-World Mucosal Healing in Vedolizumab-Treated Patients with Crohn's Disease.
- Published in:
- GastroHep, 2022, p. 1, doi. 10.1155/2022/6975416
- By:
- Publication type:
- Article
Depression, anxiety, and stress among inflammatory bowel disease patients during COVID‐19: A UK cohort study.
- Published in:
- JGH Open, 2022, v. 6, n. 1, p. 76, doi. 10.1002/jgh3.12699
- By:
- Publication type:
- Article
Semiquantitative assessment of breath hydrogen testing.
- Published in:
- Journal of Gastroenterology & Hepatology, 2013, v. 28, n. 9, p. 1450, doi. 10.1111/jgh.12199
- By:
- Publication type:
- Article
Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome.
- Published in:
- Journal of Gastroenterology & Hepatology, 2010, v. 25, n. 8, p. 1366, doi. 10.1111/j.1440-1746.2010.06370.x
- By:
- Publication type:
- Article